Hematological indicators in patients with SARS COV-2 infection
DOI:
https://doi.org/10.35381/s.v.v6i1.1725Keywords:
Hematologic agents, hematologic tests, chemical synthesis. (Source, DeCS).Abstract
Objective: To analyze hematological indicators in patients with SARS COV-2 infection. Methods: Descriptive observational study. Results: A common pattern of abnormal leukocyte count tests was found with elevated neutrophils in 43.69% (neutrophilia) and lymphocytes, but below normal values (lymphopenia) in 20.16%. In addition to monocytopenia in 13.44%. Conclusion: The detection of elevated C-reactive protein and neutrophilia is associated with severe cases of COVID-19 in adult patients. Both tests combined have high specificity and sensitivity for early prediction of severe cases of COVID -19.
Downloads
References
Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389-399. doi:10.1080/10408363.2020.1770685
Amgalan A, Othman M. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Platelets. 2020;31(6):740-745. doi:10.1080/09537104.2020.1768523
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834-847. doi:10.1002/ajh.25829
Pan F, Yang L, Li Y, et al. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study. Int J Med Sci. 2020;17(9):1281-1292. Published 2020 May 18. doi:10.7150/ijms.46614
Ghahramani S, Tabrizi R, Lankarani KB, et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):30. Published 2020 Aug 3. doi:10.1186/s40001-020-00432-3
Salamanna F, Maglio M, Landini MP, Fini M. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19). Platelets. 2020;31(5):627-632. doi:10.1080/09537104.2020.1762852
Devreese KMJ. COVID-19-related laboratory coagulation findings. Int J Lab Hematol. 2021;43 Suppl 1(Suppl 1):36-42. doi:10.1111/ijlh.13547
Moreno-Noguez M, Rivas-Ruiz R, Roy-García IA, Pacheco-Rosas DO, Moreno-Espinosa S, Flores-Pulido AA. Risk factors associated with SARS-CoV-2 pneumonia in the pediatric population. Factores de riesgo asociados con neumonía por SARS-CoV-2 en población pediátrica. Bol Med Hosp Infant Mex. 2021;78(4):251-258. doi:10.24875/BMHIM.20000263
de la Matta M, Delgado-Sánchez JM, Gutiérrez GM, López Romero JL, Del Mar Martínez Gómez M, Domínguez Blanco A. Utility of preoperative polymerase chain reaction testing during SARS-CoV-2 pandemic: The challenge of evolving incidence. Utilidad de la prueba de reacción en cadena de la polimerasa preoperatoria durante la pandemia por SARS-CoV-2: el desafío de la incidencia cambiante. Rev Esp Anestesiol Reanim (Engl Ed). 2021;68(6):346-352. doi:10.1016/j.redar.2020.10.006
Rodriguez-Nava G, Yanez-Bello MA, Trelles-Garcia DP, Chung CW, Friedman HJ, Hines DW. Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting. Int J Infect Dis. 2021;102:571-576. doi:10.1016/j.ijid.2020.11.003
Mòdol Deltell JM, Robert Boter N. Quick SOFA: A new triage scale for emergencies?. QuickSOFA: ¿una nueva escala en el triaje de pacientes urgentes?. Emergencias. 2018;30(6):383-384.
San I, Gemcioglu E, Baser S, et al. Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients. Sci Rep. 2021;11(1):21807. Published 2021 Nov 8. doi:10.1038/s41598-021-01181-x
Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. doi:10.1056/NEJMoa2001017
Cuéllar L, Torres I, Romero-Severson E, et al. Excess deaths reveal unequal impact of COVID-19 in Ecuador. BMJ Glob Health. 2021;6(9):e006446. doi:10.1136/bmjgh-2021-006446
Chauca R. La covid-19 en Ecuador: fragilidad política y precariedad de la salud pública [Covid-19 in Ecuador: political fragility and vulnerability of public health]. Hist Cienc Saude Manguinhos. 2021;28(2):587-591. doi:10.1590/S0104-59702021005000003
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
